Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.

Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD.

Int J Gynecol Cancer. 2012 Jun;22(5):778-85. doi: 10.1097/IGC.0b013e31824d836c.

PMID:
22572845
2.

Peritoneal carcinomatosis: cytoreductive surgery and HIPEC--overview and basics.

Brücher BL, Piso P, Verwaal V, Esquivel J, Derraco M, Yonemura Y, Gonzalez-Moreno S, Pelz J, Königsrainer A, Ströhlein M, Levine EA, Morris D, Bartlett D, Glehen O, Garofalo A, Nissan A.

Cancer Invest. 2012 Mar;30(3):209-24. doi: 10.3109/07357907.2012.654871. Review.

PMID:
22360361
3.

Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity.

Gill RS, Al-Adra DP, Nagendran J, Campbell S, Shi X, Haase E, Schiller D.

J Surg Oncol. 2011 Nov 1;104(6):692-8. doi: 10.1002/jso.22017. Review.

PMID:
21713780
4.

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.

In Vivo. 2009 Jul-Aug;23(4):639-44.

5.

Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence.

Mulier S, Claes JP, Dierieck V, Amiel JO, Pahaut JP, Marcelis L, Bastin F, Vanderbeeken D, Finet C, Cran S, Velu T.

Curr Pharm Des. 2012;18(25):3793-803. Review.

PMID:
22591422
6.

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.

Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.

Ann Surg Oncol. 2012 Jul;19(7):2186-94. doi: 10.1245/s10434-012-2264-z.

PMID:
22395983
7.

Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival.

Bijelic L, Kumar AS, Stuart OA, Sugarbaker PH.

Gastroenterol Res Pract. 2012;2012:163284. doi: 10.1155/2012/163284.

8.
9.

Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.

Vaira M, Cioppa T, D'Amico S, de Marco G, D'Alessandro M, Fiorentini G, De Simone M.

In Vivo. 2010 Jan-Feb;24(1):79-84.

PMID:
20133981
10.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients.

Bakrin N, Cotte E, Golfier F, Gilly FN, Freyer G, Helm W, Glehen O, Bereder JM.

Ann Surg Oncol. 2012 Dec;19(13):4052-8. doi: 10.1245/s10434-012-2510-4.

PMID:
22825772
11.

Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients.

Costa WL Jr, Coimbra FJ, Ribeiro HS, Diniz AL, de Godoy AL, Begnami M, Silva MJ, Fanelli MF, Mello CA.

World J Surg Oncol. 2012 Sep 19;10:195. doi: 10.1186/1477-7819-10-195.

12.

Clinical results of cytoreduction and HIPEC for malignant peritoneal mesothelioma.

Alexander HR, Hanna N, Pingpank JF.

Cancer Treat Res. 2007;134:343-55. Review.

PMID:
17633065
13.

Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up.

Fagotti A, Costantini B, Petrillo M, Vizzielli G, Fanfani F, Margariti PA, Turco LC, Piovano E, Scambia G.

Gynecol Oncol. 2012 Dec;127(3):502-5. doi: 10.1016/j.ygyno.2012.09.020.

PMID:
23022234
14.

HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome.

Fagotti A, Costantini B, Vizzielli G, Perelli F, Ercoli A, Gallotta V, Scambia G, Fanfani F.

Gynecol Oncol. 2011 Aug;122(2):221-5. doi: 10.1016/j.ygyno.2011.04.008.

PMID:
21543112
15.

Toxicity of hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric patients with sarcomatosis/carcinomatosis: early experience and phase 1 results.

Hayes-Jordan A, Green H, Ludwig J, Anderson P.

Pediatr Blood Cancer. 2012 Aug;59(2):395-7. doi: 10.1002/pbc.24160.

PMID:
22492588
16.

The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.

El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A.

Ann Surg Oncol. 2012 Jan;19(1):110-4. doi: 10.1245/s10434-011-1840-y.

PMID:
21701929
17.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34.

PMID:
18043976
18.

Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.

Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, Tarquini S, Di Seri M, Ciardi A, Montruccoli D, Sammartino P.

Cancer. 2008 Jul 15;113(2):315-25. doi: 10.1002/cncr.23553.

19.

HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?

Hompes D, Tiek J, Wolthuis A, Fieuws S, Penninckx F, Van Cutsem E, D'Hoore A.

Ann Oncol. 2012 Dec;23(12):3123-9. doi: 10.1093/annonc/mds173.

PMID:
22831982
20.

Peritoneal carcinomatosis from colorectal cancer: HIPEC?

Confuorto G, Giuliano ME, Grimaldi A, Viviano C.

Surg Oncol. 2007 Dec;16 Suppl 1:S149-52. Review.

PMID:
18257149

Supplemental Content

Support Center